Blockade of T-Lymphocyte KCa3.1 and Kv1.3 Channels as Novel Immunosuppression Strategy to Prevent Kidney Allograft Rejection
- 1 July 2009
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (6), 2601-2606
- https://doi.org/10.1016/j.transproceed.2009.06.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Balancing Efficacy and Toxicity in Kidney-Transplant ImmunosuppressionNew England Journal of Medicine, 2007
- Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact DermatitisJournal of Investigative Dermatology, 2007
- Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesProceedings of the National Academy of Sciences, 2006
- K+ channels as targets for specific immunomodulationTrends in Pharmacological Sciences, 2004
- Selective Blockade of Voltage-Gated Potassium Channels Reduces Inflammatory Bone Resorption in Experimental Periodontal DiseaseJournal of Bone and Mineral Research, 2004
- Calcium Signaling Mechanisms in T LymphocytesAnnual Review of Immunology, 2001
- Up-regulation of the IKCa1 Potassium Channel during T-cell ActivationJournal of Biological Chemistry, 2000
- CyclosporineNew England Journal of Medicine, 1989
- Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?Nature, 1984
- Renal Transplantation in the Rat: Details of a Technique1Anz Journal of Surgery, 1968